Investors Purchase Large Volume of Aurora Cannabis Call Options (NASDAQ:ACB)

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of unusually large options trading on Tuesday. Stock investors bought 24,073 call options on the company. This is an increase of 38% compared to the typical volume of 17,462 call options.

Institutional Investors Weigh In On Aurora Cannabis

Several institutional investors have recently made changes to their positions in the stock. Toronto Dominion Bank lifted its position in shares of Aurora Cannabis by 219.4% during the third quarter. Toronto Dominion Bank now owns 62,943 shares of the company’s stock worth $37,000 after acquiring an additional 43,236 shares in the last quarter. Vontobel Holding Ltd. lifted its position in shares of Aurora Cannabis by 67.5% during the third quarter. Vontobel Holding Ltd. now owns 125,304 shares of the company’s stock worth $73,000 after acquiring an additional 50,500 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Aurora Cannabis during the fourth quarter worth $42,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Aurora Cannabis by 6.3% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,888,202 shares of the company’s stock worth $1,690,000 after buying an additional 172,049 shares in the last quarter. Finally, Mackenzie Financial Corp purchased a new stake in shares of Aurora Cannabis in the fourth quarter worth $98,000. Hedge funds and other institutional investors own 47.63% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Friday, February 9th.

Aurora Cannabis Stock Performance

Shares of ACB stock traded up $0.89 during trading on Tuesday, hitting $7.17. The company’s stock had a trading volume of 5,556,439 shares, compared to its average volume of 4,757,427. The company has a market cap of $391.05 million, a PE ratio of -2.47 and a beta of 2.36. The company has a current ratio of 3.79, a quick ratio of 2.45 and a debt-to-equity ratio of 0.14. The business has a fifty day moving average of $4.44 and a 200-day moving average of $4.55. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $11.50.

Aurora Cannabis (NASDAQ:ACB) last released its earnings results on Thursday, February 8th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.10). Aurora Cannabis had a negative net margin of 48.82% and a negative return on equity of 23.27%. The business had revenue of $53.34 million during the quarter, compared to the consensus estimate of $45.94 million. As a group, research analysts anticipate that Aurora Cannabis will post -0.85 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.